Lv11
50 积分 2024-12-17 加入
Novel colorectal cancer screening methods — opportunities and challenges
6天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
9天前
已完结
Ageing, immune fitness and cancer
13天前
已完结
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
27天前
已完结
KRASG12D Selective VHL-PROTAC with sparing KRASWT and Other KRAS Mutants
27天前
已完结
KRAS Oncoprotein Signaling in Cancer
27天前
已完结
Routes to molecular glue degrader discovery
29天前
已完结
Assembly and function of branched ubiquitin chains
1个月前
已完结
Conquering PROTAC molecular design and drugability
1个月前
已完结
Molecular glue meets antibody: next-generation antibody–drug conjugates
1个月前
已完结
皖公网安备34019202002308
